MULTIFACETED cannabis company AltoVerde has announced the appointment of Dr Kuldip Birdi as its new Medical Director.
Dr Kuldip Birdi will help develop AltoVerde’s medical cannabis programmes as it expands from its UK base into Europe.
Dr Birdi has a distinguished career with over 15 years working for both the NHS and the pharmaceutical industry, and is now working to fully unlock the potential of the cannabis plant in partnership with AltoVerde.
Mitesh Makwana, Founder and Chairman of AltoVerde, said: “The key to unlocking the true potential of medical cannabis is through strong partnerships with the pharmaceutical industry.
“Only through such means will the pharma truly understand the benefits of cannabis based medicinal products, and the cannabis industry be able to formulate medicinal products in accordance with the country regulations.
“Dr Birdi, with his experience in both sectors is ideally suited for this role, and we look forward to working with him towards bringing greater acceptance of medicinal cannabis products both to the public and the medical sector itself”.
Dr Birdi said: “AltoVerde’s ethos is inspiring. When I was first introduced to the company, I realised immediately how AltoVerde was setting itself apart from its competitors and how unique it would become.
“I am a true believer in the patient-centred approach to management with medical cannabis which is what the company aims to do. I am excited to be part of the business at this stage and of something which will no doubt grow and shape the medical cannabis industry”.